FDA Confirms Adderall Shortage: What You Should Know

Key Points:

• Patients and pharmacists have been reporting a shortage of Adderall, a common medication used to treat ADHD.
• Supply disruptions and an increase in diagnosis and prescriptions may be contributing factors.
• Those affected may consider alternative treatment options.

The Adderall Shortage:

The supply of Adderall, a commonly used stimulant for attention-deficit/hyperactive disorder (ADHD), has been inadequate to meet the demand. Patients and pharmacists have reported shortages, with a survey showing over 60% of small pharmacies struggle to obtain the medication.

Reasons for the Shortage:

1. Supply Disruptions: Teva Pharmaceutical Industries Ltd., the primary supplier of Adderall in the US, has cited "supply disruptions" due to packaging capacity constraints, affecting both branded and generic forms of Adderall.

2. Overprescription: There has been a rise in Adderall prescriptions. Bloomberg reported a significant increase in amphetamine sales during the second quarter of 2021, the highest in nearly a decade. This increased demand, coupled with a steady supply, has led to the current shortage.

Managing the Shortage:

1. Consult with Healthcare Providers: Those affected by the shortage may experience symptoms of Adderall withdrawal, including mental and physical exhaustion and depression. Consulting healthcare providers about alternative treatment options is crucial as there are other options for managing ADHD symptoms.

2. Over-the-Counter Remedies: Over-the-counter painkillers and sleep aids can help alleviate withdrawal symptoms.

3. Self-Care: Maintaining hydration, eating a balanced diet, exercising regularly, and getting adequate rest can also aid in managing withdrawal symptoms.